IRLAB THERAPEUTICS AB SER. A financial statements, including revenue, expenses, profit, and loss

The total revenue of IRLAB_A for the last quarter is 9.03 M SEK, and it's 78.89% lower compared to the previous quarter. The net income of Q3 24 is -31.66 M SEK.